323
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Intrapartum antibiotic prophylaxis failure and group-B streptococcus early-onset disease

, , , , , , , , , & show all
Pages 1221-1224 | Received 29 Sep 2010, Accepted 03 Jan 2011, Published online: 30 Jun 2011
 

Abstract

Objectives. To determine factors influencing intrapartum antibiotic prophylaxis (IAP) failure in the prevention of group B streptococcus (GBS) early-onset disease (EOD).

Methods. GBS EOD case is defined as isolation of GBS from a normally sterile body site (e.g. blood or cerebrospinal fluid) in infants aged ≤7 days. During a consecutive 93-month period, GBS EOD cases and care data were reviewed.

Results. Seventy-nine GBS EOD cases were registered; 67 infants were born to women who received no i.v. antibiotics during labor. The 12 EOD cases exposed to IAP were more likely to be associated with emergency caesarean section (p = 0.0015), maternal obstetric risk factors (ORFs) (p = 0.0061), particularly intrapartum fever (p = 0.0002), and to present with signs of illness at birth (p = 0.0015). Correct dosages, agents, and timing were registered in three cases only; of which two were associated with intrapartum fever.

Conclusions. ORFs, emergency caesarean section, and signs of illness at birth are significantly associated with GBS EOD in infants exposed to IAP. This study also suggests that recommended IAP agents, dosages, and timing are infrequently associated with EOD. Strict protocol adherence is recommended in all cases.

Acknowledgements

Authors thank Dr. Johanna Chester, who kindly revised the manuscript and gave valuable suggestions.

Declaration of interest: This work has been supported in part by the WHO Collaborating Centre of the Italian National Health Institute Valutazione delle infezioni neonatali precoci e tardive da streptococco di gruppo B (GBS) nel nostro paese e dei sierotipi circolanti causa di malattia, grant (N PRGT 71408).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.